Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis

NCT06287684 is registered in ClinicalTrials.gov with Mater Dei Hospital, Malta as lead sponsor.

NCT NCT06287684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06287684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
Lead sponsor
Mater Dei Hospital, Malta
Phase
Observational
Overall status
Recruiting
Start date
September 13, 2023
Completion date
December 30, 2028
Enrollment
460 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock